Wednesday, May 28, 2014

June 5: Webcast - Best Practices in Prior Art Searching Life Sciences

Examine the tools that maximize search efforts and walk-through successful processes on extracting relevant data from search results
Search Strategies Examined:

  • Active pharmaceutical ingredients and formulations 
  • Biotech- sequence searching, methods and apparatus
  • Medical Devices- mechanical and electrical engineering 
  • Industrial and consumer chemistry 
  • Food chemistry and nutraceuticals 
  • Business and Database methods.
Topics Covered:
  • Search Types: What kinds of prior art searches are there?
  • Search Strategies: A guide to conducting a good search
  • Databases: Patent vs. non-patent, free vs. subscription, as well as which databases specialize in particular subject areas, along with their pros, cons and features
Best Practices in Prior Art Searching Life Sciences
June 5, 2014
12:00 PM Eastern
Feroze Ali & Jeffrey Sobek. Coming from varied technical and management backgrounds, they also bring a wealth of knowledge from more than 40 years of combined experience working with IP professionals from top IP and AmLaw firms to individual inventors.
Legal Advantage has conducted over 3,000 combined searches, with a cross section of experience of searching for patent and non-patent literature in databases mirrored with extensive on-site search experience at the USPTO.
Legal Advantage.
1 Hour in AR, CA, DE, FL, ME, MO, MT, NM, NV, OH, OK, SC, TX, UT, VA, WA.
Legal Advantage.

4freeCLE is the free Newsletter of free Continuing Legal Education.
Free CLE Sent To Your Laptop!
Free CLE
Sent To Your Laptop!
Every week, it brings to your email box more than 20 opportunities to learn about the legal profession while earning Continuing Legal Education credits.
  • Webcasts: bring CLE to your home or office
  • On-Demand: let you learn what you need when you need it
  • In-Person: traditional classroom settings give you the maximum opportunity for interaction and networking.
4freeCLE is and always will be free. Subscribe Now!

No comments:

Post a Comment